GlassScriptPhysician profile
Randy D Wolfe
NPI 1326663865
$1,034.10
in general payments reported to CMS, 2019-2025
12 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.00 · 2021: $52.52 · 2022: $160 · 2023: $314 · 2024: $234 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.36 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $265.57 | 2022-2025 | Durysta |
| Rxsight INC | $235.68 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Glaukos Corporation | $143.50 | 2020-2025 | Idose, Idosetr |
| Tarsus Pharmaceuticals, INC. | $122.82 | 2024-2025 | Xdemvy |
| Rayner Intraocular Lenses Limited | $88.55 | 2022-2024 | Omidria, Rayone Spheric, Rayone Emv |
| Bausch & Lomb Americas INC. | $54.00 | 2022-2025 | Stellaris, Scoutpro Osmolarity System |
| Oyster Point Pharma, INC. | $24.23 | 2023 | Tyrvaya |
| Allergan, INC. | $23.50 | 2022 | |
| Horizon Therapeutics Plc | $22.14 | 2022 | |
| Beaver-Visitec International, INC. | $19.31 | 2025 | |
| Biotissue Holdings INC. | $17.88 | 2022 | |
| Harrow Eye, LLC | $16.92 | 2023 | Iheezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.